OQS
CAI

Occudo Quantitative Strategies’s Caris Life Sciences CAI Stock Holding History

Occudo Quantitative Strategies’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,355
Closed -$225K – 970
2025
Q4 		$225K Buy
+8,355
New +$235K 0.02% 570

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Occudo Quantitative Strategies's CAI Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Caris Life Sciences (CAI) in Q1 2026, closing a stake of 8,355 shares — an estimated $225K sold.

Occudo Quantitative Strategies first reported a position in CAI in Q4 2025 and held it in 1 quarter. The position peaked at $225K in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Caris Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 8,355 Caris Life Sciences shares in Q1 2026, an estimated $225K.
  • Occudo Quantitative Strategies first reported a position in Caris Life Sciences in Q4 2025 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Caris Life Sciences position peaked at $225K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.